OPKO Health, Inc.
OPKNASDAQHealthcare● Active
$1.44
$-0.00(-0.31%)
Market Cap$1.1B
P/E Ratio—
52W High$1.6
52W Low$0.98
OPKO Health, Inc. (OPK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OPK · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 28, 2026EPS Actual
-$0.07
Est. -$0.07 · +0.0%
Revenue
$0.12B
Est. $0.13B · -4.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 28, 2026
After Market Close
▼ Miss Revenue✓ 3-Quarter EPS Beat Streak
OPK reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 30, 2026 | -$0.08 | — | — | — | $0.13B | — |
| — Q2 FY2026 | Apr 28, 2026 | -$0.07 | -$0.07 | +0.0% | $0.12B | $0.13B | -4.8% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.07 | -$0.04 | +42.9% | $0.15B | $0.14B | +6.3% |
| ▲ Q4 FY2025 | Oct 29, 2025 | -$0.02 | $0.03 | +250.0% | $0.15B | $0.14B | +8.5% |
| ▼ Q3 FY2025 | Jul 31, 2025 | -$0.12 | -$0.19 | -58.3% | $0.16B | $0.17B | -5.4% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -$0.06 | -$0.10 | -66.7% | $0.15B | $0.17B | -9.5% |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.08 | $0.01 | +112.5% | $0.18B | $0.16B | +18.2% |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$0.10 | $0.03 | +130.0% | $0.17B | $0.16B | +11.7% |
Q3 FY2026
Jul 30, 2026
EPS Actual
—
EPS Est.
-$0.08
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 28, 2026
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.12B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$0.04
EPS Est.
-$0.07
EPS Surpr.
+42.9%
Revenue
$0.15B
Q4 FY2025
Oct 29, 2025Beat
EPS Actual
$0.03
EPS Est.
-$0.02
EPS Surpr.
+250.0%
Revenue
$0.15B
Q3 FY2025
Jul 31, 2025Miss
EPS Actual
-$0.19
EPS Est.
-$0.12
EPS Surpr.
-58.3%
Revenue
$0.16B
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
-$0.10
EPS Est.
-$0.06
EPS Surpr.
-66.7%
Revenue
$0.15B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.08
EPS Surpr.
+112.5%
Revenue
$0.18B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$0.03
EPS Est.
-$0.10
EPS Surpr.
+130.0%
Revenue
$0.17B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.07 | $-0.07 | $-0.06 | 1 |
| Q3 FY2027 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q2 FY2027 | $-0.07 | $-0.07 | $-0.06 | 1 |
| Q1 FY2027 | $-0.07 | $-0.07 | $-0.06 | 1 |
| Q4 FY2026 | $-0.09 | $-0.08 | $-0.08 | 1 |
| Q3 FY2026 | $-0.09 | $-0.08 | $-0.07 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.1B | $0.2B | $0.2B | 3 |
| Q3 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q2 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q1 FY2027 | $0.1B | $0.1B | $0.1B | 3 |
| Q4 FY2026 | $0.1B | $0.1B | $0.1B | 5 |
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 28, 2026 | +0.0% | $1.20 | $1.21 | +0.83% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +42.9% | $1.18 | $1.20 | +1.69% |
| ▲ Q4 FY2025 | Oct 29, 2025 | +250.0% | $1.44 | $1.43 | -0.69% |
| ▼ Q3 FY2025 | Jul 31, 2025 | -58.3% | $1.34 | $1.28 | -4.48% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -66.7% | $1.40 | $1.38 | -1.43% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +112.5% | $1.66 | $1.63 | -1.81% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +130.0% | $1.47 | $1.45 | -1.36% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +88.9% | $1.34 | $1.28 | -4.48% |
Q2 FY2026+0.83%
Report Date
Apr 28, 2026
EPS Beat/Miss
+0.0%
Price Before
$1.20
Price After
$1.21
Q1 FY2026+1.69%
Report Date
Feb 26, 2026
EPS Beat/Miss
+42.9%
Price Before
$1.18
Price After
$1.20
Q4 FY2025-0.69%
Report Date
Oct 29, 2025
EPS Beat/Miss
+250.0%
Price Before
$1.44
Price After
$1.43
Q3 FY2025-4.48%
Report Date
Jul 31, 2025
EPS Beat/Miss
-58.3%
Price Before
$1.34
Price After
$1.28
Q2 FY2025-1.43%
Report Date
Apr 30, 2025
EPS Beat/Miss
-66.7%
Price Before
$1.40
Price After
$1.38
Q1 FY2025-1.81%
Report Date
Feb 27, 2025
EPS Beat/Miss
+112.5%
Price Before
$1.66
Price After
$1.63
Q4 FY2024-1.36%
Report Date
Nov 7, 2024
EPS Beat/Miss
+130.0%
Price Before
$1.47
Price After
$1.45
Q3 FY2024-4.48%
Report Date
Aug 7, 2024
EPS Beat/Miss
+88.9%
Price Before
$1.34
Price After
$1.28
Avg Beat Reaction-0.97%
Avg Miss Reaction-2.96%
Beat Rate6 / 8 quarters
Largest Move-4.48% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OPK ends December
OPKO Health, Inc. (OPK) most recently reported earnings on April 28, 2026 for Q2 FY2026, posting EPS of $-0.07 (in line with the analyst consensus of $-0.07). OPK has beaten EPS estimates for 3 consecutive quarters. The next OPK earnings date is expected around September 1, 2026.
Each quarter, investors track OPK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OPK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OPK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OPK earnings · 4 questionsOPKO Health, Inc.'s next earnings report is expected around September 1, 2026. OPK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OPK historically reports after market close (AMC).
OPK earnings datewhen is OPK earningsOPK next earnings datewhen does OPK report earningsOPK earnings calendar
▸ Source: FMP · OPKO Health, Inc. SEC filings · US GAAP · OPKO Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026